Levophacetoperane

Levophacetoperane
Clinical data
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	BR: Class C1 (Other controlled substances); In general: ℞ (Prescription only);
Identifiers
	IUPAC name [(R)-phenyl-[(2R)-piperidin-2-yl]methyl] acetate;
CAS Number	24558-01-8 ;
PubChem CID	15706387;
ChemSpider	32702188;
UNII	3SZ9ZII529;
CompTox Dashboard (EPA)	DTXSID50179295 ;
Chemical and physical data
Formula	C14H19NO2
Molar mass	233.311 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(=O)O[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2;
	InChI InChI=1S/C14H19NO2/c1-11(16)17-14(12-7-3-2-4-8-12)13-9-5-6-10-15-13/h2-4,7-8,13-15H,5-6,9-10H2,1H3/t13-,14-/m1/s1; Key:BKPLVPRTTWIDNL-ZIAGYGMSSA-N;
	(verify)

Levophacetoperane (Lidépran, Phacétoperane) is a psychostimulant developed by Rhône-Poulenc in the 1950s. The drug has been used as an antidepressant and anorectic. It is the reverse ester of methylphenidate. Phacetoperane and levophacetoperane have been used as wakefulness-promoting agents in the treatment of narcolepsy.

Clinical data

Routes of administration	Oral
ATC code	none
Legal status
Legal status	BR: Class C1 (Other controlled substances) In general: ℞ (Prescription only)
Identifiers
IUPAC name [(R)-phenyl-[(2R)-piperidin-2-yl]methyl] acetate
CAS Number	24558-01-8^Y
PubChem CID	15706387
ChemSpider	32702188
UNII	3SZ9ZII529
CompTox Dashboard (EPA)	DTXSID50179295
Chemical and physical data
Formula	C₁₄H₁₉NO₂
Molar mass	233.311 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CC(=O)O[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
InChI InChI=1S/C14H19NO2/c1-11(16)17-14(12-7-3-2-4-8-12)13-9-5-6-10-15-13/h2-4,7-8,13-15H,5-6,9-10H2,1H3/t13-,14-/m1/s1 Key:BKPLVPRTTWIDNL-ZIAGYGMSSA-N
(verify)